A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment
Clinical trial NCT01136733 · COMPLETED
Trial details
- NCT number
- NCT01136733
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-05
- Primary completion
- 2014-06-13
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.